Streetbeat News

Stock Prices

SPY

The USA PCE Price Index for August increased by 0.1%, which is below the estimated 0.2% and the prior month's 0.2%. This indicates a slower pace of inflation than expected.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:30 pm

SPY

The US Core PCE Price Index for August increased by 2.7% year-over-year, matching the estimated growth rate. This data is crucial for investors as it reflects inflation trends, which can influence Federal Reserve policy decisions.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:30 pm

SPY

The USA's goods trade balance for August was reported at -$94.26 billion, which is better than the estimated -$100.60 billion and the prior -$102.84 billion. This indicates a smaller trade deficit than expected.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:30 pm

SPY

The USA Core PCE Price Index for August increased by 0.1%, which is lower than the estimated 0.2% and the previous month's 0.2%. This indicates a slower pace of inflation, which could impact market expectations and investor sentiment.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:30 pm

SAVA

Cassava Sciences Inc (NASDAQ:SAVA) and its executives have agreed to pay over $40 million to settle SEC charges of manipulating Alzheimer's drug trial data. The SEC found that Cassava misled investors by promoting false efficacy data for its drug simufilam. The company's stock is down 10.90% in premarket trading.

Portfolio Pulse from Vandana Singh

September 27, 2024 | 12:28 pm

ADTX

Aditxt has announced a 1-for-40 reverse stock split effective at the open of trading on October 2. This corporate action is aimed at increasing the per-share trading price of its common stock.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:17 pm

MNTS

Momentus shares fell after the company received a non-compliance notice from Nasdaq. Additionally, a U.S. District Court issued a preliminary order for a derivative settlement, which will be communicated to stockholders.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:14 pm

AYTU

Aytu BioPharma shares declined following the release of disappointing Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:13 pm

IONQ

ONCO

SAVA

Cassava Sciences shares fell 16% after SEC charges for misleading Alzheimer's trial claims. Onconetix shares surged 94% following Altos Venture's 32.5% stake report. IonQ shares rose 10% after securing a $54.5 million contract with the US Air Force Research Lab.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:12 pm

NVNO

EnVVeno Medical's stock is trading lower following the announcement of a $15 million public offering, pricing 4.3 million shares at $3.50 each.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 12:12 pm